Journal
BIOMATERIALS
Volume 161, Issue -, Pages 81-94Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2018.01.037
Keywords
Chimeric peptide; Self-delivery; Membrane target; Anti-tumor therapy; Immune response
Funding
- National Natural Science Foundation of China [51690152, 21721005, 21474077]
Ask authors/readers for more resources
Nowadays, cell membrane targeting therapy has drawn much attention for its high anti-tumor effect by avoiding the cellular barriers. In this study, therapeutic agent conjugated chimeric peptide (Cp) was anchored in cracked cancer cell membranes (CCCM) to construct a self-delivery membrane system (MCp), which could relize precise cell membrane targeting therapy. It was found that compared with Cp, MCp could target to the cancer cell membrane with longer retention time, which is very crucial for in vivo applications. And the superior cell membrane targeting ability was attributed to the specific proteins (focal adhesion proteins, focal adhesion kinase, RHO family proteins, and integrin) on the CCCM surface. Importantly, the M-Cp could promote tumor-specific immune response, which further enhanced antitumor effect when combined with therapeutic agents in M-Cp. What's more, this self-delivery membrane system could be used as a template for cell membrane targeting therapy by changing the therapeutic agents as well as the CCCM, and this strategy would open a new window for various cell membrane targeting therapy. (C) 2018 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available